Evolus, Inc. (EOLS)
4.08
-0.08
(-1.92%)
USD |
NASDAQ |
Apr 07, 16:00
4.03
-0.05
(-1.23%)
After-Hours: 20:00
Evolus Total Liabilities (Quarterly) : 248.97M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| STAAR Surgical Co. | 117.44M |
| Sanara MedTech, Inc. | 67.01M |
| Quantum-Si, Inc. | 26.24M |
| Plus Therapeutics, Inc. | 12.33M |
| BioStem Technologies, Inc. | 11.06M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 225.87M |
| Shareholders Equity (Quarterly) | -23.11M |
| Debt to Equity Ratio | -6.708 |
| Current Ratio | 1.898 |
| Net Debt Paydown Yield | -1.16% |